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Small conductance Ca2+-activated K+ channels are present in inner mitochondrial membranes of guinea
pig, rat, and human cardiac ventricular mitochondria.
Of two isoforms found, SK2 and SK3, a splice variant, SK3.1 (aka 3a), is identified in guinea pig cardiac
mitochondria.
These channels protect against cardiac ischemia reperfusion injury via an O2 free radical mechanism
with mild mitochondrial uncoupling.

Abstract
We provide evidence for location and function of a small conductance, Ca2+-activated K+ (SKCa) channel
isoform 3 (SK3) in mitochondria (m) of guinea pig, rat and human ventricular myocytes.
SKCa agonists protected isolated hearts and mitochondria against ischemia/reperfusion (IR) injury;
SKCa antagonists worsened IR injury. Intravenous infusion of a SKCa channel agonist/antagonist, respectively, in
intact rats was effective in reducing/enhancing regional infarct size induced by coronary arteryocclusion.
Localization of SK3 in mitochondria was evidenced by Western blot of inner mitochondrial membrane,
immunocytochemical staining of cardiomyocytes, and immunogold labeling of isolated mitochondria. We
identified a SK3 splice variant in guinea pig (SK3.1, aka SK3a) and human ventricular cells (SK3.2) by amplifying
mRNA, and show mitochondrial expression in mouse atrial tumor cells (HL-1) by transfection with full length and
truncated SK3.1 protein. We found that the N-terminus is not required for mitochondrial trafficking but the Cterminus beyond the Ca2+ calmodulin binding domain is required for Ca2+ sensing to induce mK+ influx and/or
promote mitochondrial localization. In isolated guinea pig mitochondria and in SK3 overexpressed HL-1 cells,
mK+ influx was driven by adding CaCl2. Moreover, there was a greater fall in membrane potential (ΔΨm), and
enhanced cell death with simulated cell injury after silencing SK3.1 with siRNA. Although SKCa channel opening
protects the heart and mitochondria against IR injury, the mechanism for favorable bioenergetics effects
resulting from SKCa channel opening remains unclear. SKCa channels could play an essential role in restraining
cardiac mitochondria from inducing oxidative stress-induced injury resulting from mCa2+ overload.
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1. Introduction
Small conductance Ca2+-activated K+ channels may perform many roles including protection against
cardiac ischemia and reperfusion (IR) injury and therefore warrant additional studies regarding their location
and function, particularly in mitochondria. From this knowledge novel, targeted therapeutic strategies may be
developed to reduce IR injury. KCachannels of intermediate or small conductances are calmodulin (CaM)dependent, and gated primarily by Ca2+[1], [2], [3], [4]. These channels have small unit conductances of 3–30 (small,
SKCa) and 20–90 (intermediate IKCa) pS [5]. The opening of SKCa channels is initiated by Ca2+ binding
to calmodulin within the C-terminus of the channel that then forms a dimer [6], [7]. SKCa channels are widely
expressed in different cells [8] including blood, nerve, endothelial, and smooth, skeletal and cardiac myocytes.
There are at least three known genes encoding SKCa channels. The KCa2.3 (aka SK3) isoform was identified first
in endothelial cells and found to exert a potent, tonic hyperpolarization that reduced vascular smooth muscle
tone [9]. A decrease in endothelial IKCa and SKCa currents and decreased endothelial cell IKCa expression
during hypoxia and reoxygenation (HR) was associated with a decrease in EDHF-mediated relaxation
of porcinecoronary arteries [10]. In contrast, activation of IKCa/SKCa channels with 1-EBIO enhanced the K+ current
that was blunted by HR and restored EDHF-mediated relaxation [10]. These data indicated that IKCa/SKCachannels
are important for protecting the endothelium against HR injury. The KCa2.2 (SK2) isoform was first found
in mouse and human heart cell membranes using Western blot analysis and reverse transcription polymerase
chain reaction (RT-PCR) [11]. Later, Tuteja et al. [12] quantified SK1, SK2, and SK3 transcripts
between atria and ventricles from single, isolated mouse cardiomyocytes and reported much greater expression
of SK1 and SK2 in atria compared to ventricles, whereas SK3 levels were similar in both tissues. There was also
much greater atrial than ventricular sensitivity to action potential (AP) repolarization by apamin [12], a selective
SKCa antagonist [11], [13].
The cardioprotective roles of SKCa[14], IKCa, [10], and BKCa (big) [15], [16]channels in IR and HR injury have been
reported previously by our lab and others. We tested the functionality of SKCa channel opening [14] by
perfusing isolated hearts transiently before ischemia with the IKCa[1], [4], [17] and SK2 and SK3 [18], [19], [20], [21] channel
opener DCEBIO (DCEB). We found [14] that DCEB elicited pharmacologic pre-conditioning (PPC) protection in a
manner similar to that of the BKCa channel opener NS1619 [16]; both the specific SKCa antagonist
NS8593 [22], [23] and the ROS scavenger MnTBAP (TBAP), a dismutator of superoxide anion (O2 −), abolished the
cardioprotection [14]. Because excess reactive oxygen species (ROS) generation, depressed
mitochondrial bioenergetics, and mCa2+ overload, are major factors underlying IR injury [24], this suggested
SKCa channels may play a role in mitochondrial function. Indeed, Xu et al. [15] first identified the presence of
BKCa channels in cardiac mitochondria.
Recently, Dolga et al. [25] found that the SK2 isoform was expressed in mitochondria of neuronal HT-22 cells. At
about the same time, we furnished novel evidence for the presence of SK2 and SK3 isoforms in the inner
mitochondrial membrane (IMM) of guinea pig isolated ventricular mitochondria [14]. Based on multiple evidence
including mass spectroscopy analysis and immuno-gold electron microscopy, we found that SKCa channels are
located in ventricular mitochondria, most likely within the IMM [14]. Functionally, we found that the SKCa channel
opener DCEB, when given briefly before cardiac ischemia, reduced mitochondrial injury by reducing
mitochondrial [Ca2+] overload and excess O2 − emission, and by improving the redox state during reperfusion [14].
In the present report we have extended our prior work [14] to further characterize the mSKCa channel, including
its cardioprotective mechanism, and to identify the SK3 gene products in guinea pig, rat, and human heart. Our
aims were: a) to localize and identify SK3 isoforms in guinea pig and human cardiac mitochondria; b) to identify
the SK3 mitochondrial splice variant(s); c) to determine if the SK3 C-terminus downstream of the calmodulin
binding domain is required for mitochondrial targeting; d) to furnish evidence that the Ca2+ sensor of
SK3 faces the matrix; e) to determine if increased Ca2+ triggers K+ uptake into mitochondria in HL-1 cells
overexpressing SK3.1; f) to assess for cytoprotection against HR injury in HL-1 cells overexpressing SK3.1; and g)
to examine for exacerbation of HR injury in SK3.1 silenced HL-1 cells.

2. Materials and methods
2.1. Isolated guinea pig heart global ischemia model

The investigation conformed to the Guide for the Care and Use of Laboratory Animals (NIH Publication 85-23,
revised 1996). The appropriate committees at the Medical College of Wisconsin approved the use of guinea
pig, rat, and human heart tissue prior to initiating this study. Guinea pig hearts (250–300 g) were isolated and
prepared as described in detail [14], [16], [26], [27], [28], [29], [30]. Briefly, guinea pigs were anesthetized with ketamine
(50 mg/kg) and treated with 1000 units of heparin; after thoracotomy, the hearts were immediately perfused via
the aorta with cold Krebs-Ringer's perfusate. Hearts were instrumented with a saline-filled balloon attached to a
transducer to measure isovolumetric LVP and the entire coronary vascular system was perfused via the aorta
(retrograde flow) at constant pressure with Krebs-Ringer's solution at 37 °C. At 120 min reperfusion, hearts not
isolated for their mitochondria were stained with TTC and infarct size was determined as a percentage of total
ventricular heart weight [14], [16], [27], [30].
Isolated guinea pig hearts (n = 6 per drug group) were perfused with no drugs (control), test drugs (an
SKCa agonist and or antagonist), or the ROS scavenger TBAP, alone or in combination before and after 35 min
global (no aortic or coronary flow) ischemia. The agonist or antagonist was given 15 min before ischemia and for
15 min during reperfusion. Developed left ventricular (LV) pressure, coronary flow and heart ratewere recorded
online before, during and after ischemia. Drugs given were: 3 μM DCEB, an opener of SK2, SK3 and
IKCa channels [1], [18], [19], [20], [21]; 10 μM NS8593, a specific antagonist of SKCa channels [22], [23]; and 5 μM TBAP, a
chemical dismutator of O2 − that can enter the mitochondrial matrix [31].

2.2. In vivo rat heart regional ischemia model

Adult rats (250–300 g, n = 5 rats per drug group) of either sex were anesthestized, intubated, and artificial
respiration was initiated. The right carotid artery was cannulated to monitor blood pressure continuously. After
thoracotomy a suture was placed around the proximal LAD for reversible coronary artery occlusion that was
verified by regional epicardial cyanosis. Hearts were subjected to 35 min LAD occlusion followed by 120 min
reperfusion. For sham controls the LAD suture was placed but not tightened. Infarct size was assessed 120 min
after the regional ischemia using the Evan's Blue area at risk and TTC staining techniques for viable tissue, and
expressed as % area-at-risk. Drugs infused via the left jugular vein were saline (control), DCEB (30 μg/kg/min), or
NS8593 (100 μg/kg/min) dissolved in physiological saline. Drugs were infused 15 min before and after LAD
occlusion. Drug infusion in the shams had no effect on blood pressure. Infarct size measurements were blinded
to the drug. We conducted the in vivo procedure in the rat because it is technically easier than in the guinea pig.

2.3. Ca2+-induced K+ uptake in isolated ventricular mitochondria

Matrix K+ (mK+) was measured as we reported previously [32]. Briefly, mitochondria were incubated with 1 μM
PBFI-AM, a K+ fluorescence dye (Invitrogen), in the isolation buffer (described in Supplemental materials, S.1) for
20 min at room temperature. The suspension was diluted with isolation buffer and then centrifuged twice to
wash out extra-matrix residual dye. After entering the matrix, PBFI, in the acetylated methyl-ester (AM) form, is
cleaved from the methyl-ester by esterases and retained. The mitochondria pellet was resuspended to 0.5 mg
protein/ml in a respiration buffer (described in Supplemental materials, S.2) containing (in mM) 130 KCl, 5
K2HPO4, 20 MOPS, 2.5 EGTA, and 0.1% BSA, and adjusted to pH 7.15 with KOH. The buffer also contained
200 μM ATP, 20 μM paxilline, and 100 nM TRAM-34, to prevent potential mKATP, BKCa, and IKCa channel opening,
respectively. Mitochondria were energized with 10 mM pyruvate. Most experiments were conducted in the
presence of 500 μM quinine to block mitochondrial K+/H+ exchange (mKHE) in order to prevent extrusion of
K+ that enters the matrix. To restrict mitochondrial Ca2+-induced K+channel opening before beginning the
experiments, the respiration buffer contained 2.5 mM EGTA, which chelates most of the Ca2+ in the buffer, so
that [Ca2+] was undetectable. After adding 0.2–3 mM CaCl2 (in buffer with 2.5 mM EGTA), buffer and matrix
[Ca2+] can increase only within the nM range. This is apparent from a previous report [33] in which we measured

external and matrix [Ca2+] using a similar respiration buffer but containing 0.6 mM CaCl2 and 1 mM EGTA; this
resulted in an external [Ca2+] of 300 nM and a matrix [Ca2+] of 1000 nM. In buffer containing approximately
40 μM EGTA carried over with the mitochondria from the isolation buffer, with no added CaCl2, we observed a
basal external [Ca2+] of 80–100 nM and a matrix [Ca2+] of 210–250 nM [34], [35]. Mitochondrial K+ was monitored in
a cuvette-based spectrophotometer (QM-8, Photon Technology International, PTI) with excitation and
emission light, λex 340 and 380 nm; λem 500 nm, while adding 0–3 mM CaCl2 to the buffer. In some experiments
10 nM valinomycin, a K+ ionophore, was given to verify an increase in mK+influx and for referencing the change
of K+ influx induced by Ca2+ with or without UCL1684, another blocker of SKCa channels [36]. In other
experiments cyclosporine A (CSA) or ruthenium 360 (Ru360) was given to prevent mPTP opening or to block
Ca2+ uptake by the mitochondrial Ca2+ uniporter (MCU), respectively.

2.4. Isolation of rat/guinea pig ventricular cardiomyocytes and immunostaining of SK3
channels in rat cardiomyocytes

Cardiomyocytes were isolated from guinea pig and rat hearts by retrograde perfusion of isolated hearts with
a collagenase containing solution as we reported previously [37], [38]. First, hearts were removed from
anesthetized rats or guinea pigs; the aorta was cannulated to perfuse the coronary circulation with solution A
containing (in g/L): 11 MEME (Sigma), 1 glucose, and 2 NaHCO3 at pH 7.23 for 5 min to clear blood. After blood
was cleared, hearts were perfused for 20 min with a digestion solution containing 0.1% BSA,
75 U/ml collagenase Type II, and 1 unit/ml protease type XIV in solution A, at pH 7.23. Hearts were then
removed from the perfusion apparatus and the ventricles were minced into small pieces in
the digestion solution and incubated at 37 °C for 10 min in a shaker water bath to disperse the cells. Next
the cell suspension was filtered and centrifuged at 300 rpm for 1 min and resuspended in 5 ml Tyrode buffer (in
mM): 132 NaCl, 10 HEPES, 5 glucose, 5 KCl, 1 MgCl2 without added CaCl2, after which an equal volume of Tyrode
buffer containing 1 mM CaCl2 was slowly added. Freshly isolated guinea pig cardiomyocytes were used for
amplification of SKCa channel variants.

Freshly isolated adult rat cardiomyocytes were plated in a Laminincoated Lab-Tek chamber and incubated at
37 °C for 2 h; next, myocyteswere fixed with 4% paraformaldehyde in PBS for 15 min at room temperature
followed by fixation for 5 min in ice cold (− 20 °C) methanol. After washing three times with PBST (PBS + 0.1%
tween 20), myocytes were blocked and permeabilized with 20% goat serum with 1% BSA and 0.5% Triton X100 in PBST for 1 h at room temperature. After washing, cardiomyocytes were incubated overnight at 4 °C with
a combination of primary antibodies: goat anti-COX 1 (1:50 dilutions) and rabbit anti-SK3 (1:50 dilutions) diluted
with 1% BSA and 0.2% Triton X-100 in PBST. The next day, myocytes were incubated with secondary
antibodies, donkey anti-goat antibody conjugated to Alexa 546 and goat anti-rabbit antibody conjugated to
Alexa FITC for 2 h at room temperature in the dark. Following another washing with PBST, myocytes were
mounted on slides using SHUR/Mount™ LiquidMounting Medium, TBS (VWR) and imaged with an A1R
confocal microscope. Images were captured on 1024 × 1024 pixel CCDs with an oil immersion × 60 objective and
were saved and visualized with NIS elements AR software. To quantitate the co-localization of SK3 with COX 1,
solely a mitochondria protein, line scan analysis was performed with ImageJ to indicate the degree of overlap
between the two signals. A line across the cardiomyocyte was drawn in the merged figure and the intensity
profiles of all pixels of the two signals were plotted with a RGB profile plot program.

2.5. Amplification of SKCa channel variants from guinea pig ventricular myocytes and
human ventricles

We first amplified SKCa from total RNA to determine if a gene encoding SKCa channels exists in human ventricles
as well as in guinea pig ventricular myocytes. Total RNA was extracted from freshly isolated guinea pig
cardiomyocytes or human ventricular tissue using RNeasy mini kit (Qiagen, Crawley, UK). cDNA was synthesized
from 1 μg of total RNA with M-MLV reverse transcriptase and oligo(dT) primers and then subjected to PCR

amplification using iproof HF master mix (Bio-Rad). The presence of SK1, SK2 and SK3 isoforms in guinea pig
ventricular myocytes was detected using PCR primers (Table 1), which were designed based on coding sequence
from GenBank sequence XM_003465180 for SK1, XM_003473180 for SK2 and XM_003475583 for SK3. The
presence of the SK3 isoform in human ventricular tissue was detected using the following PCR primers:
HSK3.1F1: 5′ -ATGGACACTTCTGGGCACTT-3′ (forward) and HSK3.1R15′ -TCACGAAGAGCT-GGACTT- 3′ (reverse)
for the amino acid (a.a.) 1–346; HSK3.1F2: 5′ –GATGTTTG GAATTGTTGTTATG-GTG- 3′ (forward) and HSK3.1R2 5′
-TTAGCAACTGCTTGAACTTGT-3′ (reverse) for a.a. 290–731. All human SK3 amplification primers were designed
based on NM_001204087 coding sequence from GenBank. Reverse transcription-negative controls (no RT) were
used to ensure that there was no genomic contamination in the RNA samples in each experiment. PCR products
were analyzed by agarose gel electrophoresis and positive PCR products were sequenced.
Table 1. Specific primers for three SKCa isoforms (SK1-3) amplification from mRNA of isolated guinea
pig ventricular myocyte.
Name

GenBank #

Forward primer 5′->3′

Reverse primer 5′->3′

Range
(bp)
1–984

Length
(bp)
984

SK1N
SK1-C

XM_003465180

ATGATCGGC CACAGCCGCAAT

GGTGATGGAGATAGCCACA

XM_003465180

AGCATCTCCTCCTGGGTCAT

CAGTCTGAGGGTCAGTGGC

737

GGCACCGGA GGAGGC

871–
1608
1–999

SK2N
SK2-C

XM_003473180

ATGATCACTATACTCAGGTCCAGC

XM_003473180

AGAAGAACCAGAACATCGGCTAC

1727–
3109
1–998

1382

ATGGACACT TCTGGGCACTT

AAG TTG GTG
GCGCTGTAGAGG
AGCTGGACTTCGCGTGTATG

SK3N
SK3-C

XM_003475583
XM_003475583

CACCATCATCCTGCTGGGTT

CCTCCAGGATGGCAGTCAG

9452050

1105

999

998

2.6. HL-1 cell culture, plasmid construction and cell transfection

HL-1 cells, which are derived from a mouse atrial cardiomyocyte tumor lineage, were plated in tissue
culture flasks coated with gelatin/fibronectin and maintained in claycomb medium supplemented with 10% FBS,
0.1 mM norepinephrine, 2 mM L-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin. All cells were
cultured at 37 °C with 5% CO2 in a humidified incubator.
The full-length of SK3.1 (SK3FL) was amplified from cDNA of guinea pig ventricular myocytes using SK3CF1: 5′ACCTGCAGATGGACACTTCT-3′ as forward, and SK3CR1: 5′-ACGGATCCGCAACTGCTTGAACTTGT-3′ as reverse
primer, and then inserted into the BamHI and PstI sites of the pEGFP-N3 vector in frame with the enhanced
green fluorescence protein (EGFP) to construct SK3FL-EGFP. The 1–277 a.a. truncated of SK3.1 (SK3Δ1–277)
(Δ = truncated a.a. sequence) was amplified from SK3FL-EGFP plasmids using SK3CF3: 5′ACCTGCAGATGCTGATTTTTGGGATGTTT-3′ as forward and SK3CR1 as reverse primers. The 626–720 a.a.
truncated SK3.1 (SK3Δ626–720) was also amplified from SK3FL-EGFP plasmids using SK3CF1 as forward and SK3CR4:
5′-TCGGATCCGACGTTCTGCATCTTGGA-3′ as reverse primers. The SK3Δ1–277 and SK3Δ626–720 were also cloned into
pEGFP-N3 vector individually through the BamHI and PstI sites to make SK3Δ1–277–EGFP and SK3Δ626–720–EGFP
plasmids. All of the above constructs were verified by sequencing. HL-1 cells were transfected with plasmids
SK3FL-EGFP, SK3Δ1–277–EGFP and SK3Δ626–720–EGFP individually using jetPRIME Polyplus (New York) according to
the manufacturer's protocol.

2.7. Mitochondrial localization of overexpressed SK3.1 in HL-1 cells

Localization of overexpressed SK3.1 in HL-1 cells was observed fluoroscopically using a laser scanning confocal
microscope (Nikon AIR). HL-1 cells were plated on gelatin/fibronectin coated 35 mm glass bottom dishes (Matek,
Ashland, MA) and were transfected individually with SK3FL-EGFP, SK3Δ1–277–EGFP and SK3Δ626–720–EGFP. Fortyeight hours after cell transfection, the culture medium was replaced with Tyrode buffer and cells were loaded
with a mitochondrial specific marker, Mitotracker red (MTR, 100 nM) for 30 min at 37 °C and then washed with
Tyrode buffer. EGFP fluorescence was measured at λex488 nm and at λem515 nm; MTR was measured at
λex581 nm and at λem644 nm. Both EGFP and MTR were measured simultaneously. Mitochondrial localization
was determined by colocalization of EGFP-tagged SK3.1 full-length and truncated proteins with MTR. To
quantitate the co-localization of SK3 with the mitochondrial marker MTR in transfected HL-1 cells, line scan
analysis was performed with ImageJ as described in Section 2.4. Two lines around overexpressed SK3FL and
truncated proteins were drawn in corresponding transfected cells and the intensity profiles for each line were
analyzed separately using the ImageJ RGB profile plot program.

2.8. Determination of matrix K+ uptake in SK3.1 overexpressed HL-1 cells

Matrix K+ (mK+) was measured in HL-1 cells using the K+-sensitive fluorescent indicator PBFI; PBFI was loaded to
favor mitochondrial localization as described previously [39]. HL-1 cells were grown on glass coverslips and
individually transfected with SK3FL-EGFP, SK3Δ1–277–EGFP and SK3Δ626–720–EGFP. After 48 h, cells were
loaded with 10 μM PBFI AM for 60 min at 37 °C and then washed to remove residual extracellular PBFI.
Coverslips were then mounted in a recording chamber onto the stage of an inverted microscope (Nikon Diaphot
200) with attached camera (CoolSNAPfx Photometrics) and perfused with a K+-free mitochondrial buffer
containing (in mM): 250 sucrose, 25 Tris, 3 EGTA, 5 MgCl2, 5 Na-succinate and 5 glutamate (pH 7.3). PBFI
fluorescence was recorded at emission λem510 nm after sequential excitations at λex340 nm and λex380 nm
(DG-4, Sutter, Novato, CA) and the λ340/380 nm ratio was determined using MetaFluor software (Universal
Imaging Corporation, PA). After recording basal K+ influx for 2–3 min, cells were permeabilized with
20 μM digitonin for 2 min, followed by perfusion with the K+-free mitochondrial buffer. K+ uptake activated by
Ca2+ was determined by rapidly elevating bath concentrations of both K+ and Ca2+. To verify that a change in
the PBFI λ340/380 nm ratio was due to matrix K+ influx, 5 μM alamethicin, a 20 a.a. pore forming antibiotic, was
given to permeabilize the IMM at the end of the protocol; a fall in PBFI fluorescence after alamethicinconfirmed
mK+ influx in HL-1 cells. To quantify the mK+ flux, the ΔPBFI ratio was determined as the increase in PBFI ratio
during the initial 30 s after adding CaCl2. ΔPBFI ratio = (p − b) / b where p = peak increase, and b = baseline
before adding CaCl2.

2.9. Hypoxic stress and cell damage with SK3.1 overexpression in HL-1 cells

HL-1 cells were plated on gelatin/fibronectin coated 35 mm dishes and transfected individually with pEGFP-N3,
SK3FL-EGFP, SK3Δ1–277–EGFP and SK3Δ626–720–EGFP for 48 h. Hypoxia was induced by placing cells in a culture
medium containing glucose-free DMEM and 10 mM 2-deoxyglucose; culture dishes were then placed in an
airtight chamber in a 37 °C incubator and flushed with a hypoxic gas mixture of 95% N2 + 5% CO2. The cells were
exposed to hypoxia for 2 h, after which the hypoxic medium was replaced by a reoxygenated DMEM medium
containing 2% FBS at 37 °C with 95% air, + 5% CO2 (normoxia) for 2 h. For normoxia only (control), HL-1 cells
were kept in normal DMEM medium containing 10% FBS with 95% air + 5% CO2 at 37 °C. After 2 h the medium
was changed to DMEM with 2% FBS and the cells were cultured for another 2 h. To assess cell damage after
2 h reoxygenation, lactate dehydrogenase (LDH) release into the reoxygenated medium in hypoxic and normoxic
dishes was measured using an LDH kit (Diagnostic Chemicals Limited, Oxford, CT, USA); data were expressed as
percentage of EGFP normoxic controls (100%).

2.10. Silencing of SK3 with siRNA in HL-1 cells

To examine the effect of silencing of SK3 on HR injury, HL-1 cells were transfected with SK3 Silencer®
Select siRNA duplexes or scrambled siRNA at concentrations of 5 nM using Lipofectamine RNAiMAX (Invitrogen),
according to the manufacturer's instructions. Two Silencer® Select siRNAs for mouse Kcnn3 (SK3) exon 1
and exon 4 were obtained (ThermoFisher Scientific). Transfection was performed in serum-free OptiMEM
(Invitrogen) medium after which it was replaced with medium containing serum 4 h after transfection.
To confirm the silence of SK3 by siRNA in HL-1 cells, SK3 mRNA expression was measured with real time-qPCR.
Total RNA was extracted from HL-1 cells transfected with SK3 siRNA or scramble siRNA using RNeasy mini kit
(Qiagen, Crawley, UK). One μg of total RNA was used for cDNA synthesis with iScript cDNA synthesis kit (BioRad).
SK3 mRNA expression was measured using SYBR Green Master mix (Bio-Rad). Primers specific for
mouse gene Kcnn3 designed to detect the sequence between exon 3 and exon 4 and given an amplicon of
approximately 65 base pairs were purchased (ThermoFisher Scientific). Reactions were carried out in a Bio-Rad
7000 real-time thermocycler PCR machine using the following cycle conditions: 95 °C for 10 min, followed by
40 cycles at 95 °C for 15 s and 60 °C for 1 min. Results were normalized to β-actin levels. See Supplemental
materials, S.4 for silencing of SK3 in H9c2 cells.

2.11. Apoptotic cell death assay (TUNEL staining) after HR injury in SK3-silenced HL-1
cells

Apoptotic cell death was detected and quantified based on TUNEL assay(In Situ Cell Death Detection Kit, Roche)
according to the manufacturer's protocol. In brief, HL-1 cells grown on glass coverslips (5 coverslips per group)
were transfected with SK3 siRNA duplexes or scramble siRNA for 48 h (Section 2.10). To assess a possible role for
SK3 in HR injury, HL-1 cells that were transfected with SK3 siRNA or scramble siRNA were exposed to normoxia
(95% air + 5% CO2) or to hypoxia (95% N2 + 5% CO2) for 2 h in a medium containing 2-deoxyglucose followed by
16 h reoxygenation (20% O2 and 5% CO2) with claycomb medium containing 10% FBS. Cells were washed with
PBS and then fixed with 4% paraformaldehyde for 1 h at room temperature. Cells were permeabilized with 0.1%
Triton X-100 for 10 min at room temperature followed by incubation with a TdT enzyme and nucleotide mixture
for 1 h at 37 °C. After incubation, cell nuclei were stained with DAPI and the cells were imaged with
a fluorescence microscope. Apoptotic cell death was determined as a percentage of TUNEL-positive cells to the
total number of cells. For each group, a total of approximately 2000 cells were counted. See Supplemental
materials, S.5 for cell death in SK3-silenced H9c2 cells.

2.12. Mitochondrial membrane potential (ΔΨm) during simulated IR in SK3-silenced HL-1
cells

HL-1 cells were grown in glass bottom 35 mm dishes and transfected with SK3 siRNA duplexes described above
(Section 2.10). After 48 h, cells were loaded with 10 nM TMRM (tetramethylrodamine methyl ester), a marker of
ΔΨm, in Tyrode buffer for 30 min at 37 °C prior to simulated IR; all solutions contained 5 nM TMRM during
recordings. The cell dish was assembled with closed perfusion cell culture dish inserts (Warner Instrument) for
solution changes during recording and then mounted onto the stage of a confocal microscopy (Nikon A1R).
TMRM fluorescence (λem552 nm and λex543 nm) was first recorded in oxygenated Tyrode buffer for 6 min as
baseline and then simulated ischemia was initiated by exchanging normal Tyrode buffer with a simulated
ischemia buffer containing (in mM) 20 2-deoxyglucose, 2 NaCN, 135 NaCl, 4 KCl, 1 MgCl2, 2 CaCl2, and 10 Hepes,
pH 6.4 [38], [40]through the inlet and outlet ports of the perfusion cell culture dish inserts. After 10 min incubation
in simulated ischemia buffer, restoration of the control conditions was initiated by suffusing the cells with
normal Tyrode buffer through the cell culture dish inserts over 8 min to wash out the simulated ischemia buffer.
Fluorescent images were acquired with an A1R confocal microscope using the NIS-elements AR software (Nikon)
every 3 min during baseline and simulated IR. TMRM fluorescence intensity was analyzed off line using ImageJ.
Results were expressed as changes in fluorescence intensity relative to baseline (= 1).

2.13. Other methods

The following methods are described in Supplemental materials: S.1. Preparation of cardiac mitochondria
and inner mitochondrial membrane and Western blotting; S.2. O2 consumption in isolated cardiac mitochondria
after global IR injury; S.3. IEM localization of SK3 channel protein in human cardiac mitochondria; S.4. Silencing
of siRNA in H9c2 cells; S.5. Apoptotic cell death assay (TUNEL staining) in H9c2 cells; S.6. Mitochondrial
membrane potential (ΔΨm) during simulated IR in H9c2 cells.

2.14. Statistical analyses of heart and mitochondrial data

Data obtained from hearts and mitochondria were expressed as means ± standard error of the means (SEM).
Appropriate comparisons were made among groups that differed at a given condition or time, and within a
group over time compared to the initial control data. Statistical differences were measured across heart groups
using data collected before and after ischemia or in cells at given time points before or after hypoxia or
simulated ischemia. Differences among variables were determined by two-way multiple ANOVA for repeated
measures (Statview® and CLR Anova® software programs for Macintosh®); if F tests were significant, appropriate
post-hoc tests (e.g., Student-Newman-Keuls) were used to compare means. Mean values were considered
significant at P values (two-tailed) < 0.05.

3. Results
3.1. Cardiac effects of a SKCa channel agonist and an antagonist, and TBAP, after IR injury
in guinea pig isolated hearts and in rat hearts in vivo

We tested effects of a SKCa channel agonist (DCEB), a SKCa antagonist (NS8593), and the mitochondria-targeted
ROS scavenger TBAP vs. vehicle (IR control) on cardiac function (developed LVP) and damage (infarct size) in ex
vivo guinea pig hearts, and infarct size in in vivo rathearts. Unlike in our prior preconditioning study [14], in this
study drugs were perfused continuously before, during and after ischemia. Developed LVP (Fig. 1A) was
markedly reduced after 35 min no flow, global ischemia and 120 min reperfusion without drug treatment.
NS8593 alone had no effect to worsen developed LVP. DCEB markedly improved LVP and this effect was
reversed by NS8593. TBAP alone had no effect on LVP but completely blocked the protection afforded by DCEB.
Like function, infarct size (Fig. 1B) was markedly reduced by DCEB alone, unaffected by NS8593, and the
protection afforded by DCEB was blocked by either NS8593 or TBAP. Heart rate was not affected by any drug
and was not different before ischemia or after 30 min reperfusion. At 10 min before ischemia, and at 30 and
120 min reperfusion, heart rates (beats/min) were, respectively, for TC: 245 ± 2, 244 ± 3, 246 ± 4; for IR only:
235 ± 2, 232 ± 3, 238 ± 4; for DCEB: 245 ± 2, 246 ± 4, 248 ± 5; and for NS8593: 236 ± 2, 240 ± 5, 242 ± 3
(± SEM; P > 0.05 between groups).

Fig. 1. Developed (systolic-diastolic) LV pressure (A) and infarct size (B) after global IR injury in isolated guinea
pig hearts perfused with vehicle (IR only), 3 μM DCEB (SKCa agonist) only, and with 10 μM NS8593 (SKCablocker) or 5 μM
TBAP (dismutator of O2 ). Note that DCEB enhanced developed LVP (A) and reduced infarct size (B) vs. IR alone. NS8593 and
TBAP had no effect when given alone but blocked protective effects of DCEB. *P < 0.05 vs. IR.

To test if DCEB and NS8593 had effects on the in vivo heart, rats were infused i.v. with DCEB, NS8593, or vehicle
before and after LAD occlusion and infarct size (% ventricular area-at-risk) was assessed after 35 min of regional
ischemia and 120 min reperfusion (Fig. 2). NS8593 significantly enhanced infarct size, whereas DCEB significantly
reduced infarct size. These results highlight the functional significance and cardioprotective role of endogenous
SKCa channels in rat hearts in vivo.

Fig. 2. Infarct size (% area-at-risk) after regional ischemia (LAD occlusion) in intact rats infused i.v. with vehicle (IR only),
NS8593, or DCEB. Note that in vivo, NS8593 infusion enhanced infarct size by about 10% vs. IR only, and that DCEB infusion
reduced infarct size by about 42% vs. IR only. *P < 0.05 vs. IR.

3.2. SKCa channel agonist improved mitochondrial respiration after IR injury

The results above showed the importance of cardiac SKCa at the organ (whole heart: ex vivo and in vivo) level. To
further focus on the impact of SKCa at the mitochondrial level, we explored if the SKCa channel agonistDCEB
protected and if the antagonist NS8593 impaired mitochondrial function after IR injury (Table 2, Fig. 3). We
measured O2 consumption and calculated respiratory control index (RCI) in guinea
pig ventricular mitochondria that were isolated after 20 min reperfusion in isolated hearts treated with DCEB,
NS8593, or vehicle before and after 35 min global ischemia. When using the complex I substrate pyruvate (Table
2, Fig. 3A), we found that IR ± NS8593, but not IR + DCEB treatment, increased states 2 and 4 respiration and
decreased state 3 respiration compared to TC; RCI was markedly lower after IR ± NS8593 vs. TC. IR + DCEB
decreased states 2 and 4 respiration and increased RCI and state 3 respiration vs. IR alone. With the complex II
substrate succinate (Table 2, Fig. 3B), or with succinate plus rotenone, a complex I blocker (Table 2, Fig. 3C),
state 3 respiration was slower after IR ± NS8593 but less slow after IR + DCEB, whereas state 4 respiration was
faster after IR + DCEB vs. TC; RCI was lower after IR ± NS8593 and IR + DCEB, but IR + DCEB increased state 3
respiration and RCI vs. IR alone. The SKCaantagonist NS8593 exerted no significant effect on RCI from the effect
of IR alone. These results from isolated mitochondria confirm the functional contribution of cardiac
SKCa channels in intact hearts, and circumstantial evidence ties the changes in mitochondrial respiration, at least
in part, to mSKCa channel activation and inhibition.
Table 2. Respiration rates of isolated cardiac mitochondria energized with different mitochondria-targeted
substrates after IR injury with or without SKCa agonist DCEB or antagonist NS8593.
State 2
State 3
State 4
RCI
Pyruvate
TC
6.7 ± 0.7
222.4 ± 23.5
11.4 ± 0.7
17.6 ± 2.6
IR
65.7 ± 0.7§ 125.3 ± 53.2§ 69.0 ± 27.0§ 2.4 ± 1.1§
IR + NS8593 42.1 ± 3.4§ 115.9 ± 44.3§ 23.5 ± 12.1
5.0 ± 1.5§
⁎
⁎§
IR + DCEB 6.0 ± 3.4
179.6 ± 15.4
18.1 ± 4.7
10.2 ± 1.2⁎§
Succinate
TC
65.0 ± 0.7
457.6 ± 38.6
79.7 ± 15.4
5.8 ± 0.4
§
§
IR
73.7 ± 9.4
203.7 ± 69.0
114.6 ± 7.7
1.9 ± 0.7§
⁎
§
IR + NS8593 58.3 ± 0.7
227.1 ± 69.0
76.4 ± 16.8
2.7 ± 0.4§

IR + DCEB
Succinate
+ rotenone
TC
IR
IR + NS8593
IR + DCEB

63.0 ± 8.1

345.1 ± 28.0⁎§

110.6 ± 8.7§

3.2 ± 0.2⁎§

63.0 ± 10.7
63.0 ± 5.4
55.6 ± 4.7
61.6 ± 14.7

281.4 ± 57.0
113.2 ± 67.0§
117.3 ± 15.4§
255.3 ± 61.0⁎

77.1 ± 0.7
100.5 ± 47.6
85.1 ± 22.1
102.5 ± 5.4§

3.7 ± 0.5
1.1 ± 0.6§
1.8 ± 1.0§
2.6 ± 0.4⁎

Respiration rate (O2 consumption, nmol/min/mg protein) was measured in cardiac mitochondria isolated at
20 min perfusion after 35 min global ischemia ± NS859 or DCEB given 20 min before and for 20 min after
ischemia. RCI (respiratory control rate) = state 3/state 4. Time controls (TC) were not subject to ischemia but
75 min perfusion. n = hearts/group with 3–4 replicates within each mitochondrial pellet.
⁎P < 0.05 vs. IR only.
§P < 0.05 vs. TC.

Fig. 3. Comparative effects of SKCa channel agonist DCEB and SKCa antagonist NS8593 on O2 consumption (respiration)
in mitochondria isolated after 35 min global ischemia and 20 min reperfusion; TC: time controls. Traces represent typical
respiration responses to complex I substrate (A), complex II substrate (B) and complex II substrate with rotenone (C). Note
that RCI's were higher after hearts were treated with DCEB when compared to IR alone, and not significantly different after
hearts were treated with NS8593 compared to IR alone. See Table 2 for complete respiration data and statistical
significance.

3.3. Mitochondrial Ca2+-induced K+ uptake depended on Ca2+uptake and mSKCa channel
opening

We tested for mK+ uptake via mSKCa channels when stimulated by mCa2+ uptake through the MCU and
determined if the mK+ uptake can be blocked by another mSKCa channel antagonist, UCL1684. Representative
traces (Fig. 4A, B) and average of peak increases in mK+uptake recorded during the 250 to 260 s interval for each
treatment group are shown (Fig. 4C). Increasing the amount of CaCl2 added to the buffer increased the amount
of mK+ uptake over time (Fig. 4A, C); the highest mK+ level tended to approach that elicited by the
K+ ionophorevalinomycin. UCL1684 blocked mK+ uptake whereas addition of cyclosporine A (CSA), an inhibitor of
mPTP, did not alter mK+ uptake, indicating the mPTP was not open (Fig. 4B, C). Blocking mCa2+ uptake through
the MCU with Ru360 prevented mK+ uptake; this indicates that the mSKCa channel Ca2+ sensor is probably located
on the matrix side of the IMM.

Fig. 4. Representative changes in mitochondrial matrix K+ levels (arbitrary fluorescence units, AFU) assessed using the
K+ binding fluorescent indicator PBFI-AM. A: K+ influx induced by valinomycin (10 nM), different concentrations of CaCl2. B:
K+ influx induced by 3 mM CaCl2 without or with Ru360 (MCU inhibitor), UCL1684 (SKCa blocker) or cyclosporine A(CSA, an
inhibitor of mPTP opening). C: Data summarized from 250 to 260 s with 2–3 measurements for each of two hearts. Note:
Because of the presence of 2.5 mM EGTA, buffer and mitochondrial [Ca2+] with added 0.2–3 mM CaCl2 remain within the nM
range.

3.4. Expression of SK3 splice variants in mitochondria of ventricular myocytes of
different species

The pharmacological experiments suggest (Section 3.2) and support (Section 3.3) the functional relevance of
mSKCa channels in heart mitochondria. To confirm mSKCa localization and its molecular identity we
examined messenger RNA expression of the isoforms SK1, SK2, and SK3 in isolated guinea pig
ventricular myocytes by RT-PCR using the specific primers listed in Table 1. SK2 and SK3, but not SK1, was
amplified from guinea pig ventricular myocyte cDNA (Fig. 5A); this indicated that genes encoding SK2 and SK3
exist in guinea pig ventricular myocytes. In our previous report [14] we furnished initial evidence that SKCa channel
isoforms SK2 and SK3 are expressed in guinea pig ventricular mitochondria. For this study we focused solely on
the SK3 gene product. PCR fragments from lanes 5 and 6 (SK3) (Fig. 5A) were purified and sequenced. Redlabeled amino acids (a.a.) indicate the deduced a.a. sequences from the amplified genes (Fig. 5B). Sequence
alignments indicated that the amplified SK3 was similar to the humanSK3 named splice variant a (aka SK31) [41] which lacks the a.a. sequence 473PESPARLSCSSFPAW487 that is present in the human canonical
SK3 protein and designated as protein variant SK3c (aka SK3.2 (Fig. 5B). Thus, alternatively, the guinea pig
sequence SK3.1 might be designated SK3a due to the missing P-W sequence and SK3c for the predicted
sequence. No PCR product was obtained from templates generated in the absence of reverse transcriptase (Fig.
5A, Lane 11), thus confirming the absence of genomic contamination of the mRNA samples.

Fig. 5. Expression of mSKCa channels in guinea pig hearts. A: A representative agarose gel analysis of RT-PCR amplified SK1,
SK2 and SK3from guinea pig cardiomyocytes (lanes 1–6) and human ventricular tissue(lanes 9–10). Lane 1: SK1-N; Lane 2:
SK1-C; Lane 3: SK2-N; Lane 4: SK2-C; Lane 5: SK3-N; Lane 6: SK3-C; Lane 9: human SK3-N; Lane 10: human SK3-C; lanes 7 and
8: DNA ladder; Lane 11: RNA control. B: Alignment of SK3 splice variants. Red: deduced amino acid (a.a.) sequences from
amplified genes; Blue: P-W sequence designating SK3.2; Black dashes: guinea SK3 transmembrane (T) domains 1–6; CaMBD:
Ca2+ calmodulin binding domain; Bold: human vs. guinea pig a.a. differences; Yellow: truncated N terminus (a.a. 1–277) or Cterminus (a.a. 627–720) of SK3.1 as overexpressed in HL-1 cells (Fig. 8). C: Western blot analyses of SK3 in guinea pig heart
(Heart), heart mitochondria (Mito) and mitochondrial inner membrane (IMM). One membrane was incubated with specific
primary antibody anti-SK3 (Alomone Lab APC-103) (SK3 left panel); another membrane was incubated with the same
antibody, anti-SK3, but which was neutralized with the corresponding immunizing SK3 peptide before being added (SK3
preincubation, right panel). Tubulin, GM130, and calnexin were used to monitor purity of mitochondria and IMM; no
contamination by cytosol, Golgi, or sarcoplasmic reticular membrane protein was observed in mitochondria and IMM. ANT
was used to monitor integrity of mitochondria and IMM. Since SK3 expression is weak in mitochondria,
the protein concentration loaded in the mito lane was larger than that in heart and IMM lanes.

To further confirm the mitochondrial localization of SK3 in guinea pig heart, we examined the existence of SK3
protein in guinea pig heart, mitochondria and IMM by Western blot. Similar to the guinea pig heart, both cardiac
mitochondria and IMM expressed SK3 at 75 kDa (Fig. 5C). Moreover, a 40 kDa band also displayed an intense
response with the SK3 antibody; this suggested a truncated SK3 may also existent in mitochondria. To verify the
specificity of the SK3 bands reacting with the SK3 antibody, the anti-SK3 antibody was neutralized by preincubating it with a control antigen (immunizing peptide) before performing the Western blot. Indeed, both 75
and 40 kDa SK3 bands disappeared after the anti-SK3 was neutralized (Fig. 5C, anti-Sk3 preincubation panel).
This furnished evidence that 75 and 40 kDa bands are SK3 specific, and that SK3 is expressed explicitly in guinea
pig ventricular mitochondrial IMM.
We next examined for expression of SK3 splice variants in human ventricular tissue. First the mRNA expression
of possible SK3 splice variants in human ventricular tissue was examined by RT-PCR. The primers were designed
based on the identical a.a. sequences of guinea pig and human tissue. Lane 9 (Fig. 5A) shows that when using
human SK3.1F1 and human SK3.1R1 primers corresponding to a.a. 1–6 and a.a. 340–346 in human (h) (a.a. 1–6
and a.a. 329–335 in guinea pig) there were several bands amplified, suggesting that the amplification for the SK3
segment, a.a. 1–346 was not specific. Lane 10 (Fig. 5A) demonstrates the one specific band ∼ 1400 bp that was
amplified from human ventricular tissue by a forward primer hSK3.1F2 that covered a.a. 280–286 for guinea pig
and a.a. 290–296 for human (Methods, Section 2.5); the reverse primer hSK3.1R2 covered a.a. 714–720 for
guinea pig and a.a. 725–731 for human (Methods, Section 2.5). This band was purified and sequenced. Human
(h)SK3.1 and SK3.2 sequences (Fig. 5B) that are marked by red font show the deduced a.a. sequences from the
sequenced band. Amino acid sequence alignments demonstrated hSK3.1 was nearly identical (> 97% homology)

to the guinea pig SK3.1 with only one a.a. difference (a.a. 480) between the transmembrane 3 to the
Ca2+ calmodulin binding domain (CaMBD) region; as noted above, hSK3.1 lacks the same a.a. sequence (484P–
W498) attributed to the guinea pig SK3.2. The hSK3.2 isoform designated as splice variant 2, exhibits > 97%
homology to the a.a. 295–714 sequence of guinea pig SK3.1, but also lacks 484P–W498 of guinea pig SK3.2 and a
large portion (∼ a.a. 1–294) of the N-terminus(Fig. 5B), which defines the gene product as SK3.2 [41]; but since it
also lacks 484P-W498 present in guinea pig SK3.3, this suggests that the canonical human and guinea pig SK3
include this sequence.
We then localized SK3 channels to mitochondria of human ventricular cells by visualizing immunogold
labeled particles in isolated mitochondria with high resolution IEM (Fig. 6A). Shown are four mitochondria
containing gold particles identified as SK3 channels; all scanned mitochondria were positive for immunogold.
Negative controls (data not shown) (non-immune rabbit polyclonal serum) showed no gold particles in
any field view (see also Supplemental materials, Fig. S1). Positive controls (labeling with antibody to COX 1)
showed gold particles in mitochondria (data not shown). Moreover, Western blots show that mitochondria,
specifically the IMM, displayed a higher level of expression of mSK3 at a band size of approximately 40 kDa
compared to total human ventricular tissue (Fig. 6B).

Fig. 6. Location of mSK3 in human heart and rat cardiomyocytes. A: Immuno-electron microscopic (IEM) detection of
isolated humanventricular mitochondria immunostained with specific antibody against SK3. B: Western blot analyses of SK3
expression in human ventricular tissue (heart), mitochondria (mito) and inner mitochondrial
membrane(IMM). Tubulin confirmed purity of mitochondrial isolation, adeninenucleotide translocase (ANT) confirmed
enrichment of mitochondria and IMM, and GM130 and calnexin confirmed absence of contamination by Golgi
or sarcoplasmic reticulum membrane, respectively. C: Confocal fluorescence images of adult rat cardiomyocytes immunostained simultaneously with SK3 antibody followed by FITC conjugated secondary antibody (middle panel, Green) and COX 1
(cytochrome c oxidase) antibody, followed by Alexa Fluor 546 conjugated secondary antibody (top panel, red).
Yellow color in merged image (bottom panel) depicts SK3 localized in mitochondria; the intensity profile panel showed the
overlapping degree of SK3 with COX 1. The x-axis in the intensity profile is from top to bottom. The yellow rectangles label
the overlap areas of SK3 with COX 1.

DCEB provided protection against IR injury in rats in vivo (Fig. 2), so we examined if the SK3 channel is also
located in mitochondria of rat isolated ventricular myocytes by using a doublelabeled immunofluorescence staining technique i.e., anti-COX 1 antibody, a mitochondrial protein, for merging
with anti-SK3 antibody. Confocal microscopic imaging and quantitative liner scan analyses displayed SK3 protein
(Fig. 6C) as a longitudinal punctate label (SK3 panel) that co-localized with the COX 1 (complex IV) label (merged
panel, intensity panel), thereby showing expression of SK3 in the mitochondria of rat ventricular myocytes.
Taken together, our data demonstrate that mSK3 channels are located in human, guinea pig, and rat ventricular
mitochondria, and suggest that a hSK3.2 splice variant (but also missing the P-W sequence) is located in human
cardiac mitochondria.

3.5. SK3.1-EGFP localized to mitochondria in HL-1 cells

We next sought to determine which domain of mSK3.1 (guinea pig) is important for mitochondrial trafficking. To
do so, plasmids with full-length SK3, SK3FL-EGFP, N terminal truncated SK3, i.e. SK3Δ1–277–EGFP or C terminal

truncated SK3, i.e. SK3Δ626–720–EGFP, were transfected into HL-1 cells. Two days after transfection cells were
loaded with mitotracker red (MTR) and the location of expressed SK3FL, SK3Δ1–277and SK3Δ626–720 was examined
using confocal microscopy (Fig. 7). EGFP fluorescence revealed the distribution of EGFP tagged SK3FL (Fig. 7A),
SK3Δ626–720 (Fig. 7B) and SK3Δ1–277 (Fig. 7C) (green, left panels), and MTR displayed the mitochondrial pattern in HL1 cells (Fig. 7A–C, red, middle panels). The graphs on the right side of each merge panel show the intensity
profiles of two selected lines (regions 1 and 2), individually. The EGFP tagged proteins SK3FL, SK3Δ1–277 and SK3Δ626–
720 were expressed in a punctate, filamentous, and reticular pattern within regions of HL-1 cells. Merged images
of EGFP fluorescence and MTR (Fig. 7A–C, merge panels and intensity panels) showed that SK3FL and SK3Δ1–277,
but not SK3Δ626–720, partially co-localized with MTR, indicating mitochondrial localization of SK3.1. These results
indicate that the C-terminus, exclusive of the CaMBD, and clearly not the N-terminus, likely plays a critical role in
trafficking SK3.1 into mitochondria.

Fig. 7. SK3.1 localized into mitochondria. Top panels: Schematic of SK3FL-EGFP, SK3Δ1–277–EGFP and SK3Δ626–720–EGFP constructs.
Q sequence, poly glycine sequence; T1–6, transmembrane regions; P, selectivity pore; CaMBD, Ca2+ calmodulin binding
domain; EGFP, enhanced green fluorescence protein. Bottom panels: Confocal fluorescence images of HL-1 cells transfected
with SK3FL-EGFP (A, Green), SK3Δ626–720–EGFP (B, Green) or SK3Δ1–277–EGFP (C, Green) and stained with Mitotracker red, (MTR,
Red). Merging (orange) depicts colocalization of SK3 with MTR; the intensity profiles show the overlapping degree of SK3
with MTR. The x-axis in the intensity profile was recorded from top to bottom and from left to right for regions 1 and 2
respectively. The yellow rectangles label the overlap areas of SK3 with MTR.

3.6. Overexpression of SK3.1 enhanced Ca2+-activated K+ uptake in HL-1 cells

Our pharmacological approach demonstrated the functional relevance of Ca2+-induced activation of
mSKCa channels to promote mK+ uptake (Fig. 4). To provide further molecular evidence, we overexpressed SK3.1
and directly measured mK+ uptake in HL-1 cells using the K+-selective fluorescent indicator PBFI-AM as we
showed previously [32]. To assess the uptake of K+ into mitochondria, HL-1 cells were permeabilized
with digitonin after dye loading but before adding KCl and CaCl2 into the perfusion buffer (Fig. 8). The rate of
mK+ uptake was indicated by increased fluorescence after adding CaCl2 to the buffer. We show (Fig. 8F) a
summary of mitochondrial ΔPBFI ratio changes, as the index of mK+uptake, induced by adding CaCl2 in HL-1 cells
overexpressing EGFP, full length (FL) and 626–720 a.a. truncated (Δ626–720) SK3. In SK3FL-EGFP overexpressed
HL-1 cells, the rate of mK+ uptake (Fig. 8A, F) after adding CaCl2 was higher than that in only EGFP overexpressed
HL-1 cells (Fig. 8C, F). To further confirm that CaCl2-inducd K+ uptake in SK3FL-EGFP overexpressed HL-1 cells
occurred in mitochondria, alamethicin was added to the perfusion buffer to permeabilize the IMM. After
adding alamethicin, PBFI fluorescence fell immediately, indicating that K+ was released from mitochondria (Fig.
8B).

Fig. 8. Representative recordings of mK+ uptake activated by adding CaCl2to buffer in HL-1 cells transfected with SK3.1
constructs. Traces of PBFI fluorescence indicate changes in m[K+]. A: in SK3FL-EGFP transfected HL-1 cells; B: in SK3FL-EGFP
transfected HL-1 cells with alamethicin, a mitochondrial pore forming peptide; C: in pEGFP-N3 transfected HL-1 cells; D: in
SK3Δ626–720–EGFP transfected HL-1 cells; and E: in SK3FL-EGFP transfected HL-1 cells with apamin, a blocker of the SK3 channel.
F: averaged ΔPBFI ratios induced by adding CaCl2 to permeabilized HL-1 cells. n = 20 cells; *P < 0.05 vs. EGFP control.
Because of the presence of 3 mM EGTA and 5 mM MgCl2, mitochondrial [Ca2+] with added 2 mM CaCl2 remained within the
nM range.

In SK3FL-EGFP overexpressed HL-1 cells, adding CaCl2 increased mK+uptake (Fig. 8E, 1200 s); in contrast,
adding apamin before adding CaCl2completely blocked mK+ uptake (Fig. 8E and F, 2800 s); this indicated that the
CaCl2-induced increase in mK+ was most likely due to enhanced opening of overexpressed SK3.1 channels. In
addition, overexpression of SK3FL-EGFP (Fig. 8A, B, E), but not the truncated SK3Δ626–720-EGFP (Fig. 8D, F), caused
an increased rate of mK+ uptake in HL-1 cells in response to added CaCl2. This suggested that the distal Cterminus, the region beyond the end of CaMBD of mSK3.1, is required for Ca2+-stimulated mK+ uptake.
In addition to overexpressing SK3 protein to enhance CaCl2-induced mK+ uptake, we also tested if increased
mK+ uptake occurs when mSKCachannels are activated by DCEB. It has been reported that DCEB augments
SKCa channel activity by increasing its apparent sensitivity to Ca2+[18]; therefore, CaCl2 was included in the
experimental buffer. In digitonin permeabilized HL-1 cells, treatment with DCEB induced greater mK+ uptake
compared to no DCEB (Fig. S4, Supplemental materials); this indicated that mSKCa channels can be activated to
increase mK+ uptake by its pharmacological agonist.

3.7. Overexpression of SK3.1 protected HL-1 cells against hypoxia and reoxygenation
injury

The functional results (Fig. 1, Fig. 2, Fig. 3, Fig. 4) predicted that opening of mSK3.1 would be cytoprotective. So
we examined next if SK3.1 channel overexpression improved cellular viability against 2 h hypoxia and
2 h reoxygenation (HR) injury in HL-1 cells. Cells were transiently transfected with pEGFP-N3 or EGFP-tagged
SK3FL, SK3Δ1–277 or SK3Δ626–720 plasmids and then subjected to HR. The relative increase in LDH release after HR was
less in SK3FL and SK3Δ1–277 than in EGFP and SK3Δ626–720 transfected cells (105 ± 1%, 95 ± 0% vs. 157 ± 21%,
132 ± 26%, respectively, n = 24 dishes, P < 0.05) (Fig. 9). This suggested that overexpression of SK3.1 channels in
mitochondria protects cells against HR stress (Fig. 9) and that the protection requires the distal C-terminus
beyond the CaMBD region of mSK3 (Fig. 8). These results in a cardiac cell line support the improved LVP and

smaller infarct size in isolated ex vivo hearts (Fig. 1) and reduced infarct size in vivo hearts (Fig. 2) after DCEB
treatment. The results are also consistent with the Ca2+-activated mK+ uptake (Fig. 8, Fig. 9) because the distal C
terminal region (a.a. 626–720) is required to form an active tetramer [42].

Fig. 9. Lactate dehydrogenase (LDH) release is reduced if SK3 C-terminusis intact. HL-1 cells transfected with pEGFP-N3,
SK3FL, SK3Δ1–277 and SK3Δ626–720 were subjected to hypoxia/reoxygenation or normoxia. LDH activity was measured in
the reoxygenation medium. Data presented are means ± SE from 3 independent experiments. *P < 0.05 vs. normoxia
groups, #P < 0.05 vs. EGFP groups.

3.8. Silencing of SK3 enhanced damage to HL-1 cells induced by hypoxia and
reoxygenation

In contrast to overexpression of SK3.1, we next tested if knockdown of SK3.1 would exacerbate cell
damage after oxidative stress. We knocked down SK3 by silencer select siRNA to SK3 exon 1 and exon 4 in HL-1
cells to assess the role of endogenous SK3 in protecting cells from HR injury. We found that SK3 mRNA
expression was significantly decreased in cells treated with SK3 silencer select siRNA (24 ± 3%) compared to cells
treated with scramble siRNA (100 ± 12%) (Fig. 10A). Cell death was assessed by the TUNEL assay.
During normoxia, knockdown of SK3 in HL-1 cells induced only limited apoptotic cell death (1.5 ± 0.4%)
compared to the scramble non-silencing control (0.66 ± 0.05%) (Fig. 10B, C). But HR further exacerbated
apoptotic cell death by 26.0 ± 2.3% in the SK3 knockdown cells compared to the scramble cells (13.7 ± 1.7%)
(Fig. 10B, C).

Fig. 10. Silencing SK3 in HL-1 cells increases cell apoptosis. A: Real-time PCR assessment of SK3 relative mRNA abundance in
HL-1 cells transfected with SK3 silence siRNA or scramble siRNA. Data presented are means ± SE from 3 independent
experiments. * P < 0.05 vs. scramble siRNA groups. B: Representative TUNEL staining of HL-1 cells transfected with SK3
siRNA or scramble siRNA and subjected to normoxia (control) or to 2 h hypoxia and 16 h reoxygenation. Apoptotic nuclei
were TUNEL stained (red) and counterstained with DAPI (blue) to label nuclei. C: Quantitative analysis of TUNEL-positive HL1 cells. Mean ± SE, n = 2000 HL-1 cells per group. * P < 0.05 vs. scramble siRNA, #P < 0.05 vs. normoxia.

We explored further if knockdown of SK3 was linked directly to mitochondrial damage by examining the effects
of short-term HR on ΔΨm (TMRM fluorescence) in SK3 knockdown HL-1 cells using confocal microscopy (Fig. 11).
We found that ΔΨm slowly decreased in both SK3 and scrambled siRNA transfected cells during 10 min hypoxia

and 8 min reoxygenation (Fig. 11A, B). However, in the SK3 siRNA transfected cells there was a significantly
greater decline in ΔΨm than in scrambled siRNA transfected cells during HR (45 ± 3% vs. 78 ± 2% at 15 min,
respectively) when compared to time controls (100%) (Fig. 11).

Fig. 11. Silencing SK3 in HL-1 cells attenuates ΔΨm. HL-1 cells were transfected with SK3 silenced siRNA or scramble siRNA.
Changes in TMRM fluorescence (ΔΨm) was measured in HL-1 cells subjected to simulated ischemia (blocked respiration). A:
Time course of relative changes in ΔΨm was assessed in SK3 siRNA (n = 40 cells) or in scramble siRNA (n = 50 cells)
transfected HL-1 cells exposed to 10 min simulated ischemia followed by 8 min resuffusion of cells with normal Tyrode to
wash out the simulated ischemia buffer and restore control conditions. (Time control = no ischemia; n = 45 cells).
*P < 0.05 vs. scramble siRNA. B: Representative confocal images of TMRM fluorescence in HL-1 cells transfected with SK3
siRNA or scramble siRNA at conditions and times noted in A.

To verify that silencing of SK3 enhances the HR-induced cell damage in another cardiac cell line, we also silenced
SK3 in H9c2 cells, a rat cardiac myoblast cell line, and examined for cell apoptosis induced by HR (Fig. S2,
Supplemental materials) and for a decline in ΔΨm induced by HR (Fig. S3, Supplemental materials). These results
are consistence with the HL-1 cell data, suggesting that SK3 may protect against HR and IR-induced cell damage
in mitochondria of other cardiomyocyte cell lines. The increase in cell death with silencing of SK3 during HR is
also consistent with antagonism of SKCa channels by NS8593 to increase infarct size after regional IR in in
vivo hearts (Fig. 2).

4. Discussion

In this report we show overall that endogenous and drug-induced opening of the SKCa channel reduces infarct
size after IR injury in vivoand that the SKCa agonist DCEB improves contractility and reduces infarct size after IR
injury in ex vivo and in vivo hearts. Additionally, we provide strong molecular evidence for the cardiac
mSKCa channel in ratand human hearts that was identified in our earlier report in guinea pighearts [14]. Moreover,
we identify SK3.1 (alternatively known as SK3a) as the splice variant present in cardiac mitochondria of guinea
pigs, and human SK3.2 as the probable splice variant present in cardiac mitochondria of humans. We found that
overexpression of SK3.1 in HL-1 cells protects against HR injury. In contrast, silencing of SK3 enhances HRinduced cell death by damaging mitochondria. By overexpressing full length and N and C terminal truncated
SK3.1, we established that the C-terminus downstream of CaMBD is required for SK3.1 expression in
mitochondria, and that mK+ uptake is activated by an increase in mCa2+ that first binds to
mitochondrial calmodulin [43] to initiate mK+uptake. Together, the molecular and physiological results support a
prominent role of mSKCa channels in mitochondria and cardiac protection during IR or HR injury.

4.1. SKCa channel agonists/antagonists infer cardio-protective and anti-protective effects
of KCa channels

Our isolated heart study (Fig. 1) supports our earlier report that pharmacological pre-conditioning by DCEB or
NS1619 [14], [16] leads to an essential intermediate step, O2 − generation, in eliciting cardioprotection. Unlike for
the ΔΨm-dependent BKCa channel opening, the SKCa channel opening could be important under conditions in
which ΔΨm is reduced during oxidative stress and when m[Ca2+] is high. Importantly, when infused i.v., DCEB and
NS8593 produced a decrease and an increase, respectively, in infarct size after LAD occlusion in intact rats (Fig.
2), thus extending what we found in the ex vivo guinea pig IR model. These in vivo results suggest a translational
appeal for i.v. treatment of a SKCa channel agonist in ischemic heart disease. Pharmacological evidence for a role
of the SKCa channel in mitochondrial protection was suggested by the improved RCIs (Fig. 3) in isolated guinea
pig mitochondria after IR injury of hearts treated with DCEB. The observation that graded increases in m[Ca2+]
induce graded increases in mK+ influx that were blocked by SKCa channel blocker UCL 1684 furnished direct
evidence for Ca2+-induced mK+ uptake via mSKCachannels (Fig. 4).
We furnish novel evidence that the site of the Ca2+ sensor is intra-mitochondrial because of the lack of an
increase in mK+ flux when Ru360 was used to block the MCU (Fig. 4). This is likely the first evidence that
provides insight into the orientation of SKCa channels in mitochondria. That the cardioprotection is mediated at
the mitochondrial level is also supported by the effect of the mitochondria-targeted ROS scavenger, TBAP, since
mitochondria are the major source of cell ROS production during cardiac IR injury (Fig. 1). The importance of
cardiac mSKCa channel opening in cardioprotection warranted further molecular examination.

4.2. Mitochondrial localization and function of small conductance Ca2+-activated
K+ channels

The SKCa channels family consists of three isoforms SK1 (KCa2.1, Kcnn1), SK2 (KCa2.2, Kcnn2) and SK3
(KCa2.3, Kcnn3) [44]. These three isoforms display differential distribution in the heart. Previous
reports [11], [12], [42] showed that SK3 was expressed at similar low levels in atria and in ventricles while SK1 and
SK2 were significantly more abundant in atria. The presence of an apamin sensitive Ca2+-activated K+ current, i.e.
SK2, was reported earlier [11], [12], [42] in the sarcolemma of mouse and human cardiomyocytes; but SK3 was
expressed subcellular in mousecardiomyocytes. We were the first to report the expression and function of SK2
and SK3 channel isoforms in mitochondria of cardiomyocytes [14]. In addition, SK2 was found recently to localize
in the IMM of neuronal HT-22 cells, where SK2 activation by CyPPA attenuated mitochondrial fragmentation,
prevented loss of ΔΨm, blocked lipid peroxidation, and reduced ROS production when cells were exposed
to glutamate [25].

Based on our previous findings [14], we have extended our present study to further identify and characterize SK3
in cardiomyocyte IMM in other mammals and to search for the specifically expressed splice variant. In support
of our prior evidence for SK3 protein in guinea pig ventricular mitochondria [14], in this study we provide
additional evidence of SK3 channels locally expressed in mitochondria of rat and human
ventricular myocytes (Fig. 6A–C). We further characterized the SK3 channel splice variant in guinea pig cardiac
mitochondria and in human ventricular mitochondria by amplifying the SK3 gene using RT-PCR. After deducing
the a.a. sequence from the amplified SK3 nucleotide sequence we found that the identified guinea pig SK3
channel was splice variant 1 (SK3.1) (Fig. 5A, B). We also determined that for the human ventricular
mitochondrial SK3, the likely splice variant is 2, i.e. SK3.2, which is an N-terminal truncated variant of human SK3
(Fig. 5A, B).
Mitochondrial localization of SK3 and splice variant SK3.1 is supported by our pharmacological and molecular
evidence: a) the higher respiration rate in mitochondria from hearts treated with DCEB before and after IR
compared to IR alone (Fig. 3); b) the presence in guinea pig cardiac IMM of SK3 proteins at 75 and 40 kDa
by Western blots, which disappeared after treating SK3 antibody with the control antigen (Fig. 5C); c)

SK3 immunogold labeling of isolated human ventricular mitochondria (Fig. 6A); d) higher human SK3.2
expression in mitochondria than in total ventricular lysate (Fig. 6B); e) SK3 co-localization with mitochondrial
protein COX 1 in isolated rat cardiomyocytes (Fig. 6C); f) SK3 partially colocalizing in mitochondria when SK3 was
overexpressed in HL-1 cells (Fig. 7); and greater apoptosis(Fig. 10) and mitochondrial depolarization (Fig. 11)
after silencing of SK3 during hypoxia/simulated ischemia of HL-1 cells.
Our finding that SK3.1 locates within the IMM of ventricular myocytes is consistent with the report of Fay et
al. [45] that SK3 affectsmitochondria ROS production in neutrophils. But in a report by Tuteja et al. [42], three
isoforms of SK channels were found distributed along the Z-lines in atrial myocytes with no observation of their
location in mitochondria. The difference between our results and those of Tuteja et al. [12], [42] may be related to
the technique of permeabilization and immunostaining of SK channels in cardiomyocytes; moreover, Western
blot analysis is more sensitive than cell immunostaining.

4.3. Requirement of C-terminus of SK3.1 for mitochondrial trafficking and Ca2+-activated
K+ uptake

We have shown that SK3 localizes to mitochondria of human, rat, and guinea pig cardiomyocytes. However, it is
important to know how SK3 localizes to mitochondria, and which domain is important for trafficking and
channel function. The functional SKCa channel is a tetramer; Ca2+sensitivity is conferred via the CaMBD in the Cterminus [46]. Correct refolding, assembly, and trafficking are required for SKCa channel function. In rat neuronal
PC12 cells, deletion of the distal C-terminus reduced cell surface expression of SK3 by 75%, whereas truncated
SK3 channels were blocked from leaving the endoplasmic reticulum to migrate to the Golgi; this suggested that a
region downstream of the CaMBD region, i.e. the distal C-terminus, is required for SK3 to traffic into the
Golgi [47]. Deletion of the distal C-terminus (leucine zipper region) of the human SK4 isoform was reported to
prevent SK4 from trafficking to the cell surface and to block channel function because of improper refolding and
assembly [48], [49]. Moreover, SK3 units assemble in homo-tetrameric as well as in hetero-multimeric complexes
with SK1 and SK2 via the coiled-coil domains in the distal C-terminus of these channels [42]; this suggests that the
C-terminus is an important molecular determinant for SK3 trafficking and channel function. Our results (Fig. 8)
showed that the guinea pig truncated SK3Δ626–720 failed to traffic to mitochondria, whereas the Nterminus truncated SK3Δ1–277localized to mitochondria where it increased Ca2+-activated mK+ uptake. This
indicated that the C-terminus is required both for SK3 trafficking to mitochondria and for Ca2+-induced
mK+ activation, which is consistent with previous reports [42], [47].
Like the C-terminus, the N-terminus of the SKCa channel is highly conserved over mammalian species but with
some variations. The N-terminal a.a. sequence of SK3 displays 97% homology between human and guinea pig
(Fig. 5B), but the guinea pig SK3 sequence has one short Q region and the human SK3 has two short Q regions. A
prior report showed that the S1 segment, a.a. 274–299 of rat SK3, but not the sequence a.a. 1–274
contained peptides that might stabilize SK3 functional conformation and nuclear localization [50]. Truncation of
the region before the S1 segment, as in our construct SK3Δ1–277–EGFP (Fig. 7, Fig. 8), did not change SK3
functional conformation [51]. An electrophysiological study in PC-12 cells showed that expression of a.a. 1–299
SK3 did not affect Ca2+-sensitivity or the number of endogenous SK3 functional channels, but did reduce
sensitivity to the agonist 1-EBIO [50]. Moreover, a molecular determinant study in neuronal cells indicated that
deletion of N-terminal domain a.a. 1–271 before the S1 segment caused SK3 to be retained in the ER while the
truncated SK3 could assemble with wild type SK3 [47]. Therefore, the N-terminal domain of human SK3 may
contain information relevant for channel trafficking and delivery to the plasma membrane, but not necessarily
for SK3 channel assembly [47].
Our results (Fig. 8) also demonstrate that truncating the N-terminus a.a. 1–277 before the S1 segment did not
affect SK3 Ca2+ sensitivity; this also agrees with prior studies [47], [50]. Moreover, our results demonstrate that the
N-terminal truncated SK3 can be expressed in mitochondria, which supports the findings of Frei et al. [50], but not
those of Roncarati et al. [47]. The difference from the latter report [47] may arise because the N-terminus

truncated SK3 can assemble with endogenous SK3 to form functional tetrameric channels that traffic to
mitochondria. Also, the position of the mitochondrial localization signal is likely different from the cell
membrane and nuclear membrane localization signals. Therefore, it is interesting that in our study the Nterminus had no effect on the mSKCa trafficking to mitochondria. This contrasts with the role of the N-terminus
as a necessary component for trafficking to the plasma membrane. Though we did not identify the
mitochondrial targeting sequence, it appears highly likely that region distal from the N-terminus is required.

4.4. Mechanisms of protection by mitochondrial SKCa channels against IR or HR stress

The presence of SK3.1 channels in the IMM may indicate that they have an important function in fine-tuning
mitochondrial bioenergetics in response to a high cytosolic Ca2+-induced rise in mCa2+, perhaps
via volume control, which is largely controlled by K+ flux, or by an uncoupling effect [32] due to mKHE. It could be
that SKCa channels are activated under ischemic conditions when ΔΨm and pHm are low. This would be in contrast
to the voltage and Ca2+-dependent BKCa channels that may open primarily during reperfusion when ΔΨm and
pHm are high (state 4 respiration) and when there is an abrupt, large increase in cytosolic [Ca2+]. This notion is
consistent with how BKCa channels can modulate cell membrane potential in excitable cells.
Since SKCa channels are expressed in the cell membrane of many cell types [8], how they alter function at these
sites may aid in understanding their mechanism of function in mitochondria. For example, SK3 activation
reduced atrial fibrillation and ventricular arrhythmia [44], and electrophysiology experiments showed that
overexpression of SK3 shortened the atrial action potential duration (APD) while knockdown of SK3 prolonged
the APD [52]. Thus effects of SK3 channel activation on mK+ uptake would be expected to alter mitochondria
bioenergetics because of its effects on IMM ion homeostasis. A role of SK3 to retard cell death has been
reported in some cancer and neuronal cells. For example, in the cancer cell line MDA-MB-231, which expresses
SK3 but not SK2, inhibition of SK3 with NS8593, or knockdown of SK3 by siRNA, had a profound cytotoxic
effect on cell viability [53]. In CNS-derived cell lines that express SK1, 2 or 3 channels, activation of SK channels
with CyPPA ameliorated saturosporine-induced cell apoptosis [53].
The effects of overexpressing or silencing of SK3.1 (Fig. 8, Fig. 9, Fig. 10, Fig. 11) to alter the viability of
cardiomyocytes likely occur through mitochondrial pathways induced by IR or HR injury. Our data in intact
hearts and isolated mitochondria are consistent with those obtained in the MDA-MB-213 cancer cells [53].
Although unknown, it is possible that SKCa channels play an important role in protecting cancer cells from
oxidative injury by a mitochondrial mediated mechanism. Our results demonstrate that SK3 knockdown
increases apoptosis of myocytes, and that SK3 overexpression reduces LDH release induced by HR stress. Thus
SKCa channel agonists and antagonists may be important adjuncts for therapeutic interventions in ischemic heart
disease [44] and cancer [53], respectively. The SK3 knockdown effect and the in vivo rat modelwith infused i.v.
SKCa antagonist NS8593 suggested endogenous protection in cardiomyocytes However, NS8593 did not worsen
LVP or enhance infarct size significantly in the isolated heart model, in contrast to the in vivo and cell line results.
We used rats for the in vivo model and HL-1 cells derived from mouse for the cell model, but for the isolated
heart model we used guinea pigs. Possibilities for the difference may be due to different animal species,
differential antagonism by NS8593, or different intracellular [Ca2+] during in vivo regional IR vs. IR in the nonvolume ejecting isolated heart. NS8593 is a negative allosteric modulator of SKCa channels that inhibits
SKCa channels by decreasing their sensitivity to Ca2+ rather than by blocking the pore [54]. Such a compound has a
bell-shaped inhibitory effect on SKCa channel current [54]. The IC50 of 3 μM NS8593 is approximately at 500–
600 nM [Ca2+] [54]. Therefore, the lack of statistical evidence for protection by endogenous SK3 channel opening
in the ex vivo heart could be due to insufficient antagonism by NS8593 in that model.
Nevertheless, the mechanistic pathway of SK3 mediated protection against IR or HR induced cell dysfunction
and apoptosis remains unclear. During oxidative stress mitochondria are a major source of excess ROS
production [24]. However, there is now ample evidence that a small amount of triggering O2 − is necessary to
mediate protection by mK+ channel opening in the heart [14], [16], [24], [55], [56], [57]. Our results (Fig. 1) confirm that the

ROS scavenger TBAP abolishes BKCa[16]or SKCa[14] mediated cardioprotection in IR injury. Fay et al. [45] used human
neutrophils and granulocyte-differentiated PLB-985 cells to show that activation of SK3 channels with 1-EBIO
increased O2 − and H2O2 production in mitochondria without altering ΔΨm; this suggested that SK3 activation
induced signaling ROS production. Therefore, SK3 channel opening by DCEB or SK3 overexpression could provide
protection by inducing signaling O2 −, which then stimulates downstream pathways that help to protect the cells
from IR injury.
In isolated cardiac mitochondria we reported previously that the BKCachannel opener NS1619 could increase
resting state 4 respiration and ROS generation while maintaining ∆ Ψm[58]. Unlike our prior study on SKCa channel
opening during PPC [14], in the current study the SKCachannel agonists were given before, during, and after
ischemia; but this protocol would still trigger ROS production similar to a preconditioning effect. However, how
activation of mSKCa induces the signaling ROS production in mitochondria is unclear. We have suggested [32] that
an increase in m[K+] is replaced immediately with an increase in m[H+] via mKHE as K+ is extruded. We proposed
that at low concentrations, these K+ channel openers cause a transient increase in matrix acidity, i.e., via
a proton leak through mKHE that stimulates respiration to maintain ΔΨm, but at a cost of increased O2
−
generation due to electron leak at the respiratory complexes.
In addition to the signaling generation of ROS, an improvement in mitochondrial efficiency and reduction of
m[Ca2+] load may play an important role in triggering protection by mK+ channel opening. For the KATP channel, it
was proposed that its opening depolarizes the IMM to cause uncoupling and hasten respiration [59], [60], [61].
Subsequent ischemia would then reduce the driving force for Ca2+ influx via the MCU; this could attenuate
mCa2+ overload [62], [63] so that energized mitochondria on reperfusion would perform more efficiently. The end
result of mSKCa channel opening, like any mK+ channel opening, may be improved mitochondrial efficiency and
reduced excess m[Ca2+] and ROS production, thereby contributing to overall protection of mitochondrial
function during IR.

4.5. Summary

We have furnished novel evidence for the presence of mSKCa channels in guinea pig, rat, and human
ventricular myocyte mitochondria, and specifically, for the location of splice variant SK3.1 and SK3.2 in guinea
pig and human mitochondria, respectively. We found that the C-terminus distal to the CaMBD is likely required
both for trafficking to mitochondria and for channel function, whereas the N-terminus appears not to be
required for trafficking to mitochondria or for channel activity. Ca2+ sensing for the mSKCa channel appears to
occur in the matrix rather than in the cytosol. Overexpression or silencing of SK3 in cardiac-like cell lines results
in less or more damage after stress injury, respectively. Activation of each type of mK+ channel may converge on
a pathway that stimulates a small amount of signaling ROS necessary to trigger activation of cardioprotective
pathways. Thus the individual stages of triggering, activation, and end-effect must be well delineated to unravel
the apparently complicated mechanism underlying cardiac protection, and specifically by the mSKCa channels.
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1. Supplementary Methods
S.1. Preparation of cardiac mitochondria and inner mitochondrial membrane and Western blotting
Crude mitochondria from human ventricular tissue or guinea pig hearts were isolated using well-established
methods in our laboratory [1, 2]. After centrifugation (8,000 g) the mitochondrial pellet was resuspended in
isolation buffer for measurement of O2 consumption and matrix K+ [3, 4] or mitochondria were purified as
described by Graham [5]. Briefly, mitochondria were layered first on a 30% Percoll gradient in isolation buffer and
then centrifuged for 30 min at 95,000 g. After centrifugation, the lower part of the dense brown band containing
the purified mitochondria was collected and washed two times with isolation buffer. After purification, the
mitochondria were resuspended in isolation buffer to elute the inner mitochondrial membrane (IMM) fraction
or lysed with RIPA buffer for Western blot analysis.
Inner mitochondrial membranes (IMM) were prepared as described previously [6]. In brief, mitochondria were
incubated first in hypotonic buffer (5 mM Tris HCl, 1 mM EDTA, pH 7.4) for 15 min on ice to rupture the outer
mitochondrial membrane (OMM) and then centrifuged at 20,000 g for 10 min at 4°C. The resulting pellet,
containing mitoplasts, was resuspended again in hypotonic buffer and then sonicated to rupture the IMM. After
sonication the fragmented mitoplasts were centrifuged at 100,000 g. The enriched IMM pellet fraction was then
lysed with RIPA buffer for Western blot analysis.
Mitochondrial pellets and IMM lysates were boiled at 95 °C for 5 min and then were resolved by SDS-PAGE and
transferred onto PVDF membranes. Membranes were incubated with specific primary antibody against SK3
(Alomone). Washed membranes were incubated with the appropriate secondary antibody conjugated to
horseradish peroxidase, then immersed in an enhanced chemiluminescence detection solution (GE Healthcare),
and next exposed to X-Ray film for autoradiography. For monitoring the purity of isolated mitochondria and
IMM, blots were stripped with buffer (62.5 mM Tris-Cl, 2% SDS, and 100 mM β-mercaptoethanol at pH 6.8), and
then probed with the mitochondrial specific antibody anti-ANT (Santa Cruz) and the cytosolic specific antibody
anti-β-tubulin, the sarcoplasmic reticulum (SR) membrane marker calnexin and Golgi marker GM130 (Cell
Signaling).
S.2. O2 consumption in isolated mitochondria of cardiomyocytes after global IR injury
Mitochondria were isolated from some guinea pig hearts subjected to global ischemia and reperfusion or to no
ischemia (time control) with or without drug treatment (section 2.1). O2 consumption was measured
polarographically using a respirometer (System S200A, Strathkelvin Instruments) as we described previously [3, 713]
. The mitochondria pellet was resuspended (0.5 mg protein /ml) in respiration buffer containing (in mM) 130
KCl, 5 K2HPO4, 20 MOPS, 2.5 EGTA, 1 Na4P2O7, 0.1% BSA, pH 7.15, to measure O2 consumption. State 2
respiration was initiated with complex I substrate Na-pyruvate (10 mM) or complex II substrate Na-succinate (10
mM) with or without rotenone (4 µM). State 3 respiration was determined after adding 250 µM ADP and state 4
respiration was assessed after all ADP was phosphorylated to ATP. The respiratory control index (RCI, state
3/state 4) was determined to assess viability and function of mitochondria.
S.3. Immunoelectron microscopy localization of SK3 channel protein in human cardiac mitochondria
Immunoelectron microscopy (IEM) was used to localize SK3 in purified human cardiac mitochondria as we
reported previously for guinea pig mitochondria [14]. Briefly, the isolated mitochondria pellet was fixed with EM

fixative and then processed using the protocols of Berryman and Rodewald [15]. Immuno-labeling was performed
by floating grids on droplets of 0.1 M NaH2PO4 buffer containing 5% PB-BSA, then incubated with rabbit
polyclonal anti-SK3 (Alomone Labs) diluted 1:50 for 90 min, or with the positive control mitochondrial marker,
mouse monoclonal antibody anti-COX 1 (Complex IV, Santa Cruz) diluted at 1:500. Non-immune rabbit
polyclonal serum was used as the negative control. This step was followed by washes in PB-BSA. The sections
were then incubated with goat anti-rabbit IgG, or goat anti-mouse IgG, conjugated to 10 nM colloidal gold [15],
rinsed in distilled water, and then stained with 2% aqueous uranyl acetate. Sections were examined in a JEOL
JEM2100 TEM at 80 kV for 80,000x magnification (conditions: ORCA 1792 x2 gain, Bin 1; gamma: 0.95; normal
contrast, no sharpening).
S.4. Silencing of siRNA in H9c2 cells
Rat derived H9c2 cells are reported to be similar to primary cardiomyocytes with regard to cellular ATP levels,
bioenergetics, metabolism, function and morphology of mitochondria [16]. Thus in some experiments we chose
the rat cardiac myoblast cell line (H9c2) (American Type Culture Collection, Manassas, VA) to corroborate the
effect of silencing of SK3 on HR injury in HL-1 cells.
H9c2 cells were maintained in Dulbecco's Modified Eagle Medium (DMEM) (Invitrogen) containing high glucose
(4.5 g/L), L-glutamine, and Na-pyruvate supplemented with 10% FBS, 100 U/mL penicillin, and 100 μg/mL
streptomycin. Two silencer® select siRNAs for rat Kcnn3 (SK3) exon 1 and exon 4 were obtained (ThermoFisher
Scientific). H9c2 cells were transfected with SK3 silencer® select siRNA duplexes or scrambled siRNA at
concentrations of 5 nM using Lipofectamine RNAiMAX (Invitrogen), according to the manufacturer’s
instructions. Transfection was performed in serum-free OptiMEM (Invitrogen) medium after which it was
replaced with medium containing serum 4 h after transfection.
Total RNA was extracted from H9c2 cells 48 h post-transfection of siRNA using RNeasy mini kit (Qiagen, Crawley,
UK). One μg of total RNA was used for cDNA synthesis with M-MLV reverse transcriptase and random hexamers
primers. SK3 mRNA expression after silencing with siRNA was measured with real time-qPCR using SYBR Green
Master mix (Bio-rad). Primers specific for rat gene Kcnn3 designed to detect the sequence between exon 3 and
exon 4 and given an amplicon of approximately 65 base pairs were purchased (ThermoFisher Scientific).
Reactions were carried out in a Bio-Rad 7000 real-time thermocycler PCR machine using the following cycle
conditions: 95°C for 10 min, followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. Results were normalized
to β-actin levels.
S.5. Apoptotic cell death assay (TUNEL staining) in H9c2 cells
Apoptotic cell death was detected and quantified based on TUNEL assay (In Situ Cell Death Detection Kit, Roche)
according to manufacturer’s protocol. In brief, H9c2 cells were transfected with SK3 siRNA duplexes or scramble
siRNA for 48 h. To assess the roles of SK3 in HR injury, H9c2 cells transfected with SK3 silencer® select siRNA or
scramble siRNA were exposed to normoxia (20% O2, 5% CO2) or to hypoxia (95% N2, 5% CO2) for 4 h in a medium
containing deoxyglucose followed by 16 h reoxygenation (20% O2, 5% CO2) with the reoxygenated medium
containing 10% FBS. Cells were washed with PBS and then fixed with 4% paraformaldehyde for 1 h at room
temperature. Cells were permeabilized with 0.1% Triton X-100 for 10 min at room temperature followed by
incubation with TdT enzyme and nucleotide mixture for 1 h at 37°C. After incubation cell nuclei were stained
with DAPI and imaged with a fluorescence microscope. Apoptotic cell death was determined as percentage of
TUNEL-positive cells to the total number of cells.
S.6. Mitochondrial membrane potential (∆Ψm) during simulated IR in H9c2 cells
H9c2 cells were grown in glass bottom 35 mm dishes and transfected with SK3 siRNA duplexes described in above
section S.4. After 48 h, cells were loaded with 10 nM TMRM (tetramethylrodamine methyl ester), a marker of
∆Ψm, in Tyrode buffer for 30 min at 37°C prior to simulated IR; all solutions contained 5 nM TMRM during
recordings. The cell dish was assembled with closed perfusion cell culture dish inserts (Warner Instrument) for
solution changes during recording and then mounted onto the stage of a confocal microscopy (Nikon A1R). TMRM
fluorescence (em552 nm and ex543 nm) was first recorded in oxygenated Tyrode buffer for 6 min as baseline and
then simulated ischemia was initiated by exchanging Tyrode buffer with a buffer containing (in mM) 20 2deoxyglucose, 2 NaCN, 135 NaCl, 4 KCl, 1 MgCl2, 2 CaCl2, and 10 Hepes, pH 6.4 [17, 18] through the inlet and outlet

ports of the perfusion cell culture dish inserts. After 10 min incubation in simulated ischemia buffer, restoration
of the control conditions was initiated by suffusing the cells with normal Tyrode buffer for 8 min. Fluorescent
images were acquired with an A1R confocal microscope using the NIS-elements AR software (Nikon) every 3 min
during baseline and simulated IR. TMRM fluorescence intensity was analyzed off line using image J. Results were
expressed as changes in fluorescence intensity relative to baseline (= 1).

2. Supplementary Results and Discussion

Immunogold particles identifying SK3 signals were found only in mitochondria. These wide field IEM views of
isolated human mitochondrial preparations did not exhibit gold particles outside of mitochondria (Fig. S1).

Fig. S1. Immunoelectron microscopy. Demonstration of SK3 protein within mitochondrial but not in debris of
wide field views.
We silenced SK3 by silencer® select siRNA to SK3 exon 1 and exon 4 in H9c2 cells to assess the role of
endogenous SK3 in protecting cells from HR injury and found that SK3 mRNA expression was significantly
decreased in cells treated with SK3 silencer® select siRNA (24 ±3%) compared to cells treated with scramble
siRNA (100 ±12%) (Fig. S2A). Cell death was assessed by TUNEL assay. During normoxia silencing SK3 in H9c2
cells induced significant apoptotic cell death (15 ±2%) compared to the scramble non-silencing control (1 ±1%)
(Fig. S2). HR further exacerbated apoptotic cell death to 25 ±5% in the SK3 silenced cells compared to the
scramble cells (7 ±1%). These results are qualitatively similar to experiments in which HL-1 cells were used (Fig.
10, main text).

Fig. S2. Silencing of SK3 on H9c2 cell death. A. Real-time PCR
assessment of SK3 relative mRNA abundance of H9c2 cells transfected with SK3 silenced siRNA or scramble

siRNA. Data presented are means ±SE from 3 independent experiments. * P <0.05 vs. scramble siRNA groups. B.
Representative TUNEL staining of H9c2 cells transfected with SK3 siRNA or scramble siRNA and subjected to
normoxia (control) or to 4 h hypoxia and 16 h reoxygenation. Apoptotic nuclei were TUNEL stained (red) and
counterstained with DAPI (blue) to label nuclei. C. Quantitative analysis of TUNEL-positive H9c2 cells. Mean ±SE,
n = 300 H9c2 cells per group. * P < 0.05 vs. scramble siRNA, # P < 0.05 vs. normoxia.
We examined effects of short-term simulated ischemia on ∆Ψm (TMRM fluorescence) in SK3-silenced H9c2 cells
using confocal microscopy (Fig. S3) and found that ∆Ψm slowly decreased in both SK3 and scramble siRNA
transfected cells during 10 min simulated ischemia and 5 min post-ischemia (restored respiration) (Fig. S3).
However, in SK3 siRNA transfected cells there was a greater decline in ∆Ψm than in scramble siRNA transfected
cells at 10 min ischemia (54 ±5% vs. 74 ±4% of control (100%). Moreover, at the onset of reperfusion the
scramble siRNA H9c2 cells exhibited higher recovery of ∆Ψm (92 ±5% of control) than SK3 silenced cells (64 ±7%
of control) at the one min reperfusion. These results are qualitatively similar to experiments in which HL-1 cells
were used (Fig. 11, main text).

Fig. S3. Silencing of SK3 on H9c2 m. H9c2 cells were
transfected with SK3 silenced siRNA or scramble siRNA. TMRM fluorescence (less negative m) was measured in
H9c2 cells subjected to simulated ischemia and reperfusion. A. Representative time course of relative m
assessed in SK3 siRNA or in scramble siRNA transfected H9c2 cells exposed to 10 min simulated ischemia and 5
min with restored respiration. B. Quantitative analysis of m assessed at 10 min ischemia and 1 min of restore
respiration and normalized to baseline. Mean ±SE, n = 10 H9c2 cells per group. *P < 0.05 vs. scramble siRNA. C.
Representative confocal images of TMRM fluorescence in H9c2 cells transfected with SK3 siRNA or scramble
siRNA at 10 min simulated ischemia and 1 min restored respiration.
In addition to overexpressing SK3 protein to enhance CaCl2-induced mK+ uptake, we also tested if increased mK+
uptake occurs when mSKCa channels are activated by DCEB. It has been reported that DCEB augments SKCa
channel activity by increasing its apparent sensitivity to Ca2+ [19]; therefore, Ca2+ was included in the
experimental buffer. In digitonin permeablized HL-1 cells, treatment with DCEB induced greater mK+ uptake
compared to no DCEB (Fig. S4.); this indicated that mSKCa channels can be activated to increase mK+ uptake by
pharmacological agonists.

Fig. S4. DCEB increases the mK+ uptake in HL-1 cells. HL-1 cells permeablized with digitonin were first
incubated with or without 10 µM DCEB for 20 min. The uptake of mK+ was measured as described and
presented in main text sections (2.8 and 3.6). DCEB was present before and during recording of the data. Note
that the PBFI ratio changed over time before and after adding KCl and CaCl2. The presence of DCEB enhanced
the rise in mK+ flux compared to the vehicle (no DCEB).

References
[1] A.K. Gadicherla, D.F. Stowe, W.E. Antholine, M. Yang, A.K. Camara, Damage to mitochondrial complex I
during cardiac ischemia reperfusion injury is reduced indirectly by anti-anginal drug ranolazine, Biochim
Biophys Acta, 1817 419-429.
[2] M. Yang, D.F. Stowe, K.B. Udoh, J.S. Heisner, A.K. Camara, Reversible blockade of complex I or inhibition of
PKCbeta reduces activation and mitochondria translocation of p66Shc to preserve cardiac function after
ischemia, PLoS One, 9 (2014) e113534.
[3] A. Heinen, A.K. Camara, M. Aldakkak, S.S. Rhodes, M.L. Riess, D.F. Stowe, Mitochondrial Ca2+-induced K+
influx increases respiration and enhances ROS production while maintaining membrane potential, Am J
Physiol Cell Physiol, 292 (2007) C148-156.
[4] M. Aldakkak, D.F. Stowe, Q. Cheng, W.M. Kwok, A.K. Camara, Mitochondrial matrix K+ flux independent of
large-conductance Ca2+-activated K+ channel opening, Am J Physiol Cell Physiol, 298 (2010) C530-541.
[5] J.M. Graham, Purification of a crude mitochondrial fraction by density-gradient centrifugation, Current
protocols in cell biology, Chapter 3 (2001) Unit 3 4.
[6] M. Ogbi, I. Obi, J.A. Johnson, An inhibitor of the ∂PKC interaction with the d subunit of F1Fo ATP synthase
reduces cardiac troponin I release from ischemic rat hearts: utility of a novel ammonium sulfate
precipitation technique, PLoS One, 8 (2013) e70580.
[7] M.L. Riess, A.K. Camara, A. Heinen, J.T. Eells, M.M. Henry, D.F. Stowe, KATP channel openers have opposite
effects on mitochondrial respiration under different energetic conditions, J Cardiovasc Pharmacol, 51
(2008) 483-491.
[8] M.L. Riess, Eells JT, Kevin LG, Camara AKS, Henry MM, Stowe DF, Attenuation of mitochondrial respiration by
sevoflurane in isolated cardiac mitochondrial is mediated in part by reactive oxygen species,
Anesthesiology, 100 (2004) 498-505.
[9] A. Heinen, M. Aldakkak, D.F. Stowe, S.S. Rhodes, M.L. Riess, S.G. Varadarajan, A.K. Camara, Reverse electron
flow-induced ROS production is attenuated by activation of mitochondrial Ca2+-sensitive K+ channels, Am
J Physiol Heart Circ Physiol, 293 (2007) H1400-1407.
[10] M. Huang, A.K. Camara, D.F. Stowe, F. Qi, D.A. Beard, Mitochondrial inner membrane electrophysiology
assessed by rhodamine-123 transport and fluorescence, Ann Biomed Eng, 35 (2007) 1276-1285.
[11] C.A. Blomeyer, J.N. Bazil, D.F. Stowe, R.K. Pradhan, R.K. Dash, A.K. Camara, Dynamic buffering of
mitochondrial Ca2+ during Ca2+ uptake and Na+-induced Ca2+ release, J Bioenerg Biomembr, 45 (2013)
189-202.

[12] A.D. Boelens, R.K. Pradhan, C.A. Blomeyer, A.K. Camara, R.K. Dash, D.F. Stowe, Extra-matrix Mg2+ limits Ca2+
uptake and modulates Ca2+ uptake-independent respiration and redox state in cardiac isolated
mitochondria, J Bioenerg Biomembr, 45 (2013) 203-218.
[13] C.A. Blomeyer, J.N. Bazil, D.F. Stowe, R.K. Dash, A.K. Camara, Mg2+ differentially regulates two modes of
mitochondrial Ca2+ uptake in isolated cardiac mitochondria: implications for mitochondrial Ca2+
sequestration, J Bioenerg Biomembr, 48 (2016) 175-188.
[14] D.F. Stowe, A.K. Gadicherla, Y. Zhou, M. Aldakkak, Q. Cheng, W.M. Kwok, M.T. Jiang, J.S. Heisner, M. Yang,
A.K. Camara, Protection against cardiac injury by small Ca2+-sensitive K+ channels identified in guinea pig
cardiac inner mitochondrial membrane, Biochim Biophys Acta, 1828 (2013) 427-442.
[15] M.A. Berryman, R.D. Rodewald, An enhanced method for post-embedding immunocytochemical staining
which preserves cell membranes, J Histochem Cytochem, 38 (1990) 159-170.
[16] A.V. Kuznetsov, S. Javadov, S. Sickinger, S. Frotschnig, M. Grimm, H9c2 and HL-1 cells demonstrate distinct
features of energy metabolism, mitochondrial function and sensitivity to hypoxia-reoxygenation,
Biochim Biophys Acta, 1853 (2015) 276-284.
[17] L.K. Seidlmayer, V.V. Juettner, S. Kettlewell, E.V. Pavlov, L.A. Blatter, E.N. Dedkova, Distinct mPTP activation
mechanisms in ischaemia-reperfusion: contributions of Ca2+ ROS, pH, and inorganic polyphosphate,
Cardiovasc Res, 106 (2015) 237-248.
[18] F. Sedlic, M. Muravyeva, A. Sepac, M. Sedlic, A.M. Williams, M. Yang, X. Bai, Z.J. Bosnjak, Targeted
modification of mitochondrial ROS production converts high glucose-Induced cytotoxicity to
cytoproteition: Effects on anesthetic preconditioning, J Cell Physiol, (2016).
[19] P. Pedarzani, J.E. McCutcheon, G. Rogge, B.S. Jensen, P. Christophersen, C. Hougaard, D. Strobaek, M.
Stocker, Specific enhancement of SK channel activity selectively potentiates the afterhyperpolarizing
current I(AHP) and modulates the firing properties of hippocampal pyramidal neurons, The Journal of
biological chemistry, 280 (2005) 41404-41411.

